chartexchange

BetterLife Pharma Appoints LifeSci Advisors as Investor Relations Firm

Newsfile | Oct 27, 2026 8:00 AM EDT

Vancouver, British Columbia--(Newsfile Corp. - October 27, 2026) - BetterLife Pharma Inc. (CSE: BETR) (OTCQB: BETRF) (FSE: NPAU) ("BetterLife" or the "Company"), a biotechnology company developing BETR-001 for chronic cluster headache and chronic migraine, today announced that it has retained LifeSci Advisors ("LifeSci" or "LifeSci Advisors") to support its investor relations and corporate communications activities. The engagement of LifeSci is being completed pursuant to the policies of the...

Read original article